Adenoviral VEGF-DΔN ΔC gene therapy for myocardial ischemia
Background: Cardiovascular diseases are the leading cause of death globally. In spite of the availability of improved treatments, there is still a large group of chronic ischemia patients who suffer from significant symptoms and disability. Thus, there is a clear need to develop new treatment strate...
Guardado en:
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Frontiers Media S.A.
2022-12-01
|
| Colección: | Frontiers in Bioengineering and Biotechnology |
| Materias: | |
| Acceso en línea: | https://www.frontiersin.org/articles/10.3389/fbioe.2022.999226/full |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|